Study may accelerate identifying patients who need liver transplants

Measuring blood levels of a short-lived protein helped predict which patients would survive without the help of a transplant

9:15 AM

Author | Jina Sawani

liver drawing red and green
Getty Images

Nearly 3,000 Americans are diagnosed with acute liver failure, or ALF, each year. While acetaminophen overdose is often associated with this condition, prescription medications, herbal supplements and viruses like hepatitis A and B can yield the same results. 

“Most individuals with acetaminophen-associated ALF can recover without a liver transplant,” said Robert Fontana, M.D., professor of internal medicine and transplant hepatology researcher at Michigan Medicine. “But it’s no surprise that there’s a tremendous need for transplant organs that far exceeds what’s actually available.”

But recent findings from Fontana and a team of fellow experts from Rutgers University, the University of Texas Southwestern Medical Center and the Medical University of South Carolina may enable a faster and more accurate way to identify patients who are hospitalized and in need of liver transplants or are likely to recover. Their research was recently published in Clinical Gastroenterology and Hepatology.

Their study, which involved a retrospective analysis of blood samples and medical records from 270 patients who were admitted to the hospital with acute liver failure, revealed that concentrations of a short-lived and abundant serum protein called carbamoyl phosphate synthetase 1, or CPS1, helped predict which patients survived without a liver transplant.

SEE ALSO: Many Popular Dietary Supplements Can Yield Dangerous Liver Results (michiganmedicine.org)

“Any prognostic tool that helps distinguish patients likely to recover from those likely to die from ALF, while transplant candidates are still healthy enough to survive surgery, is extremely valuable,” said Fontana, who is also a leading investigator in the study of acute liver failure and drug-induced liver injury. “That’s why this work is so important.”

The same team of researchers has systemically established CPS1’s potential as such a tool. Their previous work has shown that the protein only reaches the blood when acute hepatotoxicants damages CPS1-rich liver cells that then leads to its release into blood.

SEE ALSO: Liver Damage More Commonly Due to Malignant Tumors than Cancer Immunotherapy Drug (michiganmedicine.org)

Previous studies also show that the protein has a short half-life. If the liver starts recovering and cell death slows down or stops — a strong indication that a patient will survive without a transplant — blood-borne CPS1 decreases rapidly within hours.

“In this study, we reviewed records and samples from 103 patients with acetaminophen-induced liver failure and 167 with liver failure from other causes,” said Fontana. “Patients from the first group who received liver transplants or died within 21 days of hospitalization had, on average, about twice as much CPS1 in the blood as those who spontaneously recovered.”

SEE ALSO: Liver Transplant Recipient Fights Off COVID-19 (michiganmedicine.org)

Fontana notes that patients from the second group who died or received transplants also had higher CPS1 levels than those who recovered: “Notably, about a third higher. However, we calculated an 11% chance that this was a coincidence.”

The team’s research also revealed an increase of CPS1 when comparing day three with day one of hospitalization, but other liver enzymes that are normally followed indicators of injury, were not found in a higher percentage of patients with acetaminophen-induced acute liver failure who died or required liver transplantation.

“We still need to validate these results in more patients to further confirm that CPS1 levels predict ALF from causes other than acetaminophen,” said Bishr Omary, senior vice chancellor for academic affairs and research at Rutgers Biomedical and Health Sciences and senior author of the study. “But this has the potential to be a highly valuable prognostic and clinical management tool for acetaminophen and other causes of liver failure.”

SEE ALSO: Antibiotics Side Effects: Drug-Induced Liver Injury from Z-Paks (michiganmedicine.org)

Paper cited: “The role of CPS1 as a prognostic biomarker in patients with acetaminophen induced acute liver failure,” Clinical Gastroenterology and Hepatology. DOI: 10.1016/j.cgh.2023.03.002


More Articles About: All Research Topics Industry DX Liver Disease Liver Conditions & Procedures Lab Tests Liver Transplant
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories pills floating blue pink dark background physician in middle looking at chart white coat scrubs
Health Lab
Better medical record-keeping needed to fight antibiotic overuse, studies suggest
Efforts to reduce overuse of antibiotics may be hampered by incomplete medical records that don’t show the full reasons for prescriptions.
surgery gloves passing tool blue and yellow
Health Lab
A universal heparin reversal drug is shown effective in mice
The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.
zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
blue gloves in hospital hanging IV bag
Health Lab
Commonly used antibiotic brings more complications, death in the sickest patients
In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
yellow grey heart black background
Health Lab
Researchers create human aortic aneurysm model to advance disease understanding, treatment testing
Using human cells in an animal body, a team of researchers has developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition.